"With time, I started to notice my symptoms improving. Now I'm able to go about my day with less symptoms getting in my way."
Exciting news for patients! Xiidra is covered for approx 90%* of patients across Commercial and Medicare prescription plans!
Over-the-counter† eye drops typically work to lubricate the eye and may provide temporary relief.
Xiidra treats the signs and symptoms of dry eye disease and may offer lasting relief.‡
*Based on data from February 2024. Up to 71% of Medicare Part D and 94% of commercial patients may be covered.
†Over-the-counter=artificial tears.
‡Xiidra reduced symptoms of eye dryness at 2 weeks in 2 out of 4 studies, with improvements observed at 6 and 12 weeks in all 4 studies in some patients with continued twice-daily use.
May offer lasting relief of symptoms in as little as 2 weeks for some patients with continued twice-daily use‡
Specifically targets a source of inflammation that can cause chronic dry eye
Approximately 1,550,000 patients|| have been prescribed Xiidra
Commercially insured patients may pay as little as $0 for prescriptions of Xiidra#
‡Xiidra reduced symptoms of eye dryness at 2 weeks in 2 out of 4 studies, with improvements
observed at 6 and 12 weeks in all 4 studies in some patients with continued twice-daily use.
||Based on an analysis of IQVIA LRx claims data from July 2016 to January 2024
#For your first 30-day, 60-day, or 90-day prescription. Subject to Terms & Conditions.
Xiidra has been studied in more than 1000 patients with dry eye in 4 separate 12-week clinical studies. In some patients at 12 weeks, Xiidra was shown to reduce symptoms of eye dryness in all 4 studies and Inferior fluorescein Corneal Staining Score in 3 of 4 studies.
Xiidra may not work for everyone, but we hope it works for you. Ask your eye doctor if Xiidra is right for you.
Get the full scoop about how Xiidra performed in clinical trials—plus additional Indication and Important Safety Information—by reading the Full Prescribing Information for Xiidra.
‡Xiidra reduced symptoms of eye dryness at 2 weeks in 2 out of 4 studies, with improvements observed at 6 and 12 weeks in all 4 studies in some patients with continued twice-daily use.
In clinical studies, Xiidra was
shown to, on average:
Reduce dry eye
symptoms at
6 AND
12 WEEKS‡
Provide relief in some patients in
as little as 2 weeks‡
Reduce signs of dry eye
(the things your doctor can assess)
BY WEEK 12 IN
SOME PATIENTS
Instill 1 drop of Xiidra twice daily, approximately 12 hours apart, into each eye using the single-use container. Discard the single-use container immediately after using in each eye.
Xiidra (lifitegrast ophthalmic solution) 5% is a prescription eye drop used to treat the signs and symptoms of dry eye disease.
Do not use Xiidra if you are allergic to any of its ingredients. Seek medical care immediately if you get any symptoms of an allergic reaction.
The most common side effects of Xiidra include eye irritation, discomfort or blurred vision when the drops are applied to the eyes, and an unusual taste sensation.